| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.097 | 0.05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.038 | 0.4 |